ACTA1 and metabolic dysfunction-associated steatohepatitis: To elucidate the mechanism underlying the anti‐NASH and anti‐fibrotic effects, immunostaining of F4/80, α‐SMA, and calculation of positive area ratio were performed using a liver sample.